Solux Completes 25B Won Convertible Bond Issuance... Deep 42.6% Discount Conversion Price Intensifies Shareholder Dilution
Solux completed the issuance of 25 billion won in unsecured private convertible bonds (8th series). The payment date is May 29, 2026. Funds are allocated to operating capital (9 billion won), debt repayment (7.2 billion won), and acquisition of equity securities (8.8 billion won).
The conversion price is set at 3,453 won, a 42.6% discount from the closing price of 6,020 won prior to the announcement. This unfavorable condition may create downward pressure on the stock price when converted shares are released into the market.
Conversion would issue approximately 7.24 million new shares, representing 14.67% of current outstanding shares. Including existing unconverted CBs, total potential dilution reaches 20.56 million shares (41.69% of issued shares), significantly diluting existing shareholders.
The underwriter, In the Money Co., Ltd. (capital 10 million won, equity 290 million won) may become the largest shareholder with 12.80% upon conversion, signaling potential control change risk.
Bondholders can exercise put options quarterly after one year at a yield of 8% compounded annually. The issuer can exercise a call option after paying 5 billion won to In the Money.
Collateral includes joint first-priority beneficial interests on properties in Magok, Wonju, and Gongju (130% of face value, approximately 32.5 billion won). The company's weak financials (2025 sales 120 million won, net loss 220 million won, equity 290 million won) raise doubts about repayment ability.
[AI Final Analysis]This CB issuance, with a steep 42.6% discount and potential dilution of up to 41.69%, severely harms existing shareholder value. Given the company's fragile financial health, additional debt burden and control risk pose high risks for investors.
KOSDAQ Filing Information
Filing: Securities Issuance Result (Voluntary Disclosure) (8th Series CB)